The Membrane Technology Market is bound to reach USD 10,886 at a CAGR of 9.1% between 2022-2027. The current scenario is such that on-demand healthcare storage is being asked for. Cloud computing thus curtails operational expenses and capital as it simplifies sharing medical records, creates and maintains telehealth apps, and automates backend operations. This would be the scene with the healthcare vertical in the upcoming period.
According to a new market report published by Persistence Market Research “Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2027” the global membrane technology market for pharmaceutical, biopharma and life sciences is estimated at USD 7,029.9 million in 2022 and is expected to grow at a CAGR of 9.1% from 2022 to 2019, to reach an estimated value of USD 10,886.0 million in 2027.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3024
The membrane technology market in pharmaceutical, biopharma and life sciences is growing due to increased research and development and production in pharmaceutical, biopharmaceutical and life sciences industries. Moreover, stringent regulations and usage of single-use disposable technique are also playing a major role in growth of the membrane technology market.
Presence of various filtration techniques such as ultrafiltration, nanofiltration and microfiltration under membrane technology has increased its acceptance in pharmaceutical, biopharmaceutical and life science industries for separation and purification of components and biomolecules, over conventional techniques.
Company Profiles:
- Pall Corporation.
- Sartorius.
- 3M.
- Merck Millipore.
- GE Healthcare Life Sciences.
- Koch Membrane Systems Inc.
- Novasep.
- TriSep Corporation.
- Amazon Filters Ltd.
- Advantec MFS.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3024
However, the market faces some restraints such as effects of membrane fouling, high operational and investment cost and limitation of membrane materials. As a result, the market is expected to grow at a CAGR of about 9.1% during 2014-2019.
North America is the largest market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. The U.S. is the world’s largest market for pharmaceutical and biopharmaceutical products. According to the European Federation of Pharmaceutical Industries and Associations, North America accounted for about 41% of global pharmaceutical sales in 2012.
Similarly, in Europe, membrane technology is a rapidly growing sector with many associations, organizations and societies actively involved in expansion and implementation of this technology in various industries including pharmaceutical, biopharmaceutical and life sciences.
However, Asia is the fastest growing region in the membrane technology market due to continuous development in pharmaceutical and biopharmaceutical industries.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3024
The global market of membrane technology in pharmaceutical, biopharma and life sciences is segmented as follows:
Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences, By Technology
- Ultrafiltration
- Microfiltration
- Nanofiltration
- Chromatography
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com